We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£495.00
It has never been this cheap. We have no record of a lower price.
£495 today · cheaper than every other day in the last 3 months
Aneurysmal Subarachnoid Hemorrhage Drugs Outlook China 2023-2028
We'll watch every seller, every day. One email when your price arrives.
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 38 days · 38 data points (no recent data)
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price Distribution
Price distribution over 38 days • 1 price levels
Price Analysis
Most common price: £495 (38 days, 100.0%)
Price range: £495 - £495
Price levels: 1 different prices over 38 days
Description
Key Features
Covers latent demand outlook for aneurysmal subarachnoid hemorrhage drugs across all Chinese regions and provinces.
Provides potential industry earnings estimates in millions of U.S. dollars for approximately 1,100 cities throughout China.
Includes market analysis for major municipalities such as Beijing, Chongqing, Shanghai and Tianjin.
Analyzes special administrative regions including Hong Kong, Macau and Taiwan within the broader China market framework.
Published by ICON Group International, Inc. with 2023-2028 forecast period for strategic planning purposes.
Product Specifications
- Format
- paperback
- ASIN
- B0BBK3XN63
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 16 August 2022
- Listed Since
- 24 August 2022
Similar Products You Might Like
2023-2028 Uterine Sarcoma Therapeutics & Diagnostics Outlook - China
2023-2028 Acute Agitation Aggression Treatments Outlook China
2023-2028 Injectable Drug Delivery Devices Outlook China
2023-2028 Orphan Diseases Therapeutics CNS China Outlook
2023-2028 Orphan Diseases Oncology Therapeutics Outlook China
2023-2028 Nasal Drug Delivery Outlook for China - Market Research
2023-2028 Hypercalcemia Treatment Outlook for China
2023-2028 Compact Advance Radiotherapy Systems Outlook - China
The 2023-2028 Outlook for Pet Veterinary Drugs in China
The 2023-2028 Outlook for Antidepressant and Anti-Anxiety Drugs in the United States
The 2023-2028 Outlook for Chemotherapy-Induced Serotonin Receptor Antagonists for Nausea and Vomiting Drugs in the United States
The 2023-2028 Outlook for Pharmaceuticals for US Zip Codes
China Contraceptive Implantable Drug Delivery Devices 2023-2028 Outlook
2023-2028 Asthma Spacers Outlook China - Market Analysis
2023-2028 Home Health Care Services Outlook for China
The 2023-2028 Outlook for Orphan Biologic Drugs in India
The 2023-2028 Outlook for Chemotherapy-Induced Nausea and Vomiting Drugs in the United States
The 2023-2028 Outlook for Neurology in the United States
The 2023-2028 Outlook for Chemotherapy-Induced Serotonin Receptor Antagonists for Nausea and Vomiting Drugs in India
The 2019-2024 Outlook for Antibody Drugs in China
The 2023-2028 Outlook for Anti-Viral Nucleotide Polymerase Inhibitor Drugs in the United States
The 2023-2028 Outlook for Anti-Inflammatory Asthma Drugs in India
The 2023-2028 Outlook for Pain Management Therapeutics for US Zip Codes